APA (7th ed.) Citation

Toft, M., Mata, I. F., Ross, O. A., Kachergus, J., Hulihan, M. M., Haugarvoll, K., . . . Farrer, M. J. (2007). Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Movement Disorders, 22(3), 389. https://doi.org/10.1002/mds.21217

Chicago Style (17th ed.) Citation

Toft, Mathias, et al. "Pathogenicity of the Lrrk2 R1514Q Substitution in Parkinson's Disease." Movement Disorders 22, no. 3 (2007): 389. https://doi.org/10.1002/mds.21217.

MLA (9th ed.) Citation

Toft, Mathias, et al. "Pathogenicity of the Lrrk2 R1514Q Substitution in Parkinson's Disease." Movement Disorders, vol. 22, no. 3, 2007, p. 389, https://doi.org/10.1002/mds.21217.